Cypress Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,650	Closed	-$458K	–	138
2019 Q3	$458K	Sell	1,650 -210	-11%	-$62.1K	0.16%	107
2019 Q2	$582K	Sell	1,860 -5	-0.3%	-$1.67K	0.2%	101
2019 Q1	$766K	Sell	1,865 -108	-5%	-$44.5K	0.26%	97
2018 Q4	$737K	Sell	1,973 -575	-23%	-$210K	0.28%	91
2018 Q3	$1.03M	Sell	2,548 -357	-12%	-$136K	0.3%	89
2018 Q2	$1M	Sell	2,905 -435	-13%	-$136K	0.3%	90
2018 Q1	$1.15M	Sell	3,340 -3,791	-53%	-$1.32M	0.34%	86
2017 Q4	$2.68M	Sell	7,131 -1,446	-17%	-$586K	0.58%	57
2017 Q3	$3.83M	Sell	8,577 -1,343	-14%	-$639K	0.83%	41
2017 Q2	$4.87M	Sell	9,920 -2,052	-17%	-$898K	1%	34
2017 Q1	$4.64M	Sell	11,972 -722	-6%	-$268K	0.89%	36
2016 Q4	$4.66M	Buy	12,694 +89	+0.7%	+$33.8K	0.89%	36
2016 Q3	$5.07M	Sell	12,605 -350	-3%	-$140K	1.01%	31
2016 Q2	$4.52M	Sell	12,955 -1,125	-8%	-$433K	0.9%	32
2016 Q1	$5.08M	Sell	14,080 -65	-0.5%	-$26.8K	1.03%	32
2015 Q4	$7.68M	Sell	14,145 -400	-3%	-$217K	1.54%	18
2015 Q3	$6.76M	Sell	14,545 -50	-0.3%	-$26.9K	1.42%	20
2015 Q2	$7.45M	Hold	14,595	–	–	1.4%	22
2015 Q1	$6.59M	Buy	14,595 +2,830	+24%	+$1.2M	1.23%	24
2014 Q4	$4.83M	Buy	11,765 +225	+2%	+$88.5K	0.89%	36
2014 Q3	$4.16M	Sell	11,540 -1,405	-11%	-$471K	0.75%	44
2014 Q2	$3.66M	Sell	12,945 -1,885	-13%	-$559K	0.63%	54
2014 Q1	$4.45M	Sell	14,830 -1,655	-10%	-$510K	0.81%	41
2013 Q4	$4.54M	Sell	16,485 -400	-2%	-$115K	0.79%	41
2013 Q3	$5.28M	Sell	16,885 -35	-0.2%	-$9.21K	0.98%	33
2013 Q2	$3.81M	Buy	+16,920	New	+$3.94M	0.71%	44